ERC-USA: ERC Granted FDA Fast Track Designation for Sitoigan

ISNES, Belgium, July 26, 2022 (GLOBE NEWSWIRE) -- ERC Belgium S.A. (ERC), today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Sitoiganap (Gliovac or ERC1671)

Related Keywords

Australia , United States , Risnes , Waals Gewest , Belgium , Canada , Netherlands , America , Kostenloser Wertpapierhandel , Apostolos Stathopoulos , Jules Abraham , Partners Inc , Epitopoietic Research Corporation , Drug Administration , Fast Track , Priority Review , Research Corporation , Granted , Mast , Track , Resignation , Itoiganap , Patients , Recurrent , Glioblastoma ,